Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2065]
News [2970]
Articles [104]
Editorials [22]
Conferences [186]
elearning [62]
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity
Dr Linda Lindström - University of California at San Francisco, San Francisco...
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity ( Dr Linda Lindström - University of California at San Francisco, San Francisco, USA )
12 May 2017
GTX-024 for androgen receptor positive breast cancer
Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA
GTX-024 for androgen receptor positive breast cancer ( Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA )
12 May 2017
Adaptive trial design on breast cancer
Prof Laura Vant Veer - University of California San Francisco, San Francisco...
Adaptive trial design on breast cancer ( Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA )
11 May 2017
Identifying cancer in dense breast tissue
Cheryl Cruwys - Breast Density Matters UK
Identifying cancer in dense breast tissue ( Cheryl Cruwys - Breast Density Matters UK )
3 May 2017
Novel bi-specific TCR-based reagents for targeted cancer immunotherapy
Dr Joseph Dukes - Immunocore Limited, Abingdon, UK
Novel bi-specific TCR-based reagents for targeted cancer immunotherapy ( Dr Joseph Dukes - Immunocore Limited, Abingdon, UK )
27 Apr 2017
Discovering genes in mammary cancer by insertional mutagenesis
Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017
Centrosomes in ovarian cancer
Dr Fanni Gergely - CRUK Cambridge Institute
Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )
27 Apr 2017
Hallmarks of cancer cell development
Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017
Nivolumab and ipilimumab combination for advanced skin cancer
Dr James Larkin - The Royal Marsden, London, UK
Nivolumab and ipilimumab combination for advanced skin cancer ( Dr James Larkin - The Royal Marsden, London, UK )
12 Apr 2017
Long-term clinical outcomes and analyses of atezolizumab for mTNBC
Prof Peter Schmid - Barts Cancer Institute, London, UK
Long-term clinical outcomes and analyses of atezolizumab for mTNBC ( Prof Peter Schmid - Barts Cancer Institute, London, UK )
12 Apr 2017
Checkmate 067 - combined nivolumab and ipilimumab
Dr Suzanne Topalian - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Checkmate 067 - combined nivolumab and ipilimumab ( Dr Suzanne Topalian - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017
Durable responses to avelumab in patients with Merkel cell carcinoma
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Durable responses to avelumab in patients with Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation